Menu

AVITA Medical, Inc. RCEL

Full chart Compare
Set alert

Price alert · RCEL

All alert types
17.34 USD -0.31 (-1.78%)

Nov 11, 2026, 12:10 PM EST

17.12 Day range 18.24
3.22 52-week range 18.43
YTD
+402.46%
1 year
+337.75%

Revenue & Expenses

Revenue by
United States → Revenue: $68.79MRevenue → Gross Profit: $58.82MGross Profit → Expenses: $58.82MRevenue → Cost of Revenue: $12.79MExpenses → Selling, General & Admin: $80.51MExpenses → Research & Development: $20.84MExpenses → Interest Expense: $5.00MExpenses → Other Expenses: $1.04MExpenses → Income Tax: $11.00KNet Loss → Expenses: $48.59MJapan → Revenue: $2.09MAustralia → Revenue: $200.00KEuropean Union → Revenue: $49.00KGross Profit$58.82MNet Loss$48.59MCost of Revenue$12.79MExpenses$107.40MSelling, General & Admin$80.51MResearch & Development$20.84MInterest Expense$5.00MOther Expenses$1.04MIncome Tax$11.00KRevenue$71.61MUnited States$68.79MJapan$2.09MAustralia$200.00KEuropean Union$49.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

RCEL annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Jun 30, 2021
71.61M64.25M51.57M37.64M31.29M
58.82M55.16M43.79M31.59M25.34M
-42.53M-56.59M-42.66M-27.50M-26.54M
-48.59M-61.84M-35.38M-26.66M-26.58M
-1.74-2.39-1.40-1.07-1.17
RCEL annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Jun 30, 2021
10.24M14.05M22.12M18.16M110.95M
56.39M79.71M111.64M98.26M125.50M
73.04M74.97M61.89M12.97M9.85M
45.12M45.09M41.51M306.00K878.00K
-16.65M4.50M49.06M84.74M115.66M
RCEL annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Jun 30, 2021
-31.20M-48.94M-38.01M-19.09M-25.90M
12.45M37.36M1.61M-19.33M-1.17M
14.94M3.51M40.37M900.00K64.05M
-1.64M-9.17M-1.38M-452.00K-894.00K
-3.81M-8.07M3.95M-37.55M37.11M